HF
STOK icon

HRT Financial’s Stoke Therapeutics STOK Stock Holding History

HRT Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,955
Closed -$146K – 3197
2024
Q3 		$146K Buy
+11,955
New +$169K ﹤0.01% 2021
2023
Q2 		– Sell
-69,440
Closed -$578K – 3252
2023
Q1 		$578K Sell
69,440
-38,842
-36% -$350K 0.01% 1258
2022
Q4 		$999K Buy
108,282
+48,963
+83% +$509K 0.01% 967
2022
Q3 		$761K Buy
+59,319
New +$945K 0.01% 1106
2022
Q1 		– Sell
-18,057
Closed -$433K – 3826
2021
Q4 		$433K Buy
+18,057
New +$431K ﹤0.01% 2010

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

HRT Financial's STOK Position: Q4 2024 in Review

HRT Financial sold out of Stoke Therapeutics (STOK) in Q4 2024, closing a stake of 11,955 shares — an estimated $146K sold.

HRT Financial first reported a position in STOK in Q4 2021 and held it in 5 quarters. The position peaked at $999K in Q4 2022. 130 funds tracked by Wall St. Rank hold STOK as of Q4 2024.

  • HRT Financial reported no remaining Stoke Therapeutics position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 11,955 Stoke Therapeutics shares in Q4 2024, an estimated $146K.
  • HRT Financial first reported a position in Stoke Therapeutics in Q4 2021 and held it in 5 quarters.
  • HRT Financial's Stoke Therapeutics position peaked at $999K in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.